Telehealth & Digital Health

Aethlon Medical's upcoming financial report is more than a balance sheet; it's a test of viability for its revolutionary Hemopurifier blood filter.

A new study reveals molecular and AI-imaging tests provide distinct clues for Parkinson's, championing a dual-biomarker approach for earlier, more accurate diagnosis.

A breakthrough in cardiac fibrosis treatment reveals more than a new drug; it signals a systemic shift. How AI and human 'organoids' are making animal models obsolete.

A pivotal trial completes enrollment at a record pace while the AMA lays the groundwork for billing. ShiraTronics is rewriting the medtech playbook.

While competitors build complex apps, Maxwell TEC is winning the home care market with simple SMS. Their milestone is a strategic signal for patient engagement.

A $1.6M grant to a local college reveals a deeper strategy: leveraging community partnerships to fix the foundational cracks in Canada's healthcare system.

AbbVie secures EU approval for AQUIPTA as an acute migraine therapy, creating a dual-use drug that challenges rivals and reshapes patient care strategy.

Beyond robots, Compal and NVIDIA are building the digital nervous system for healthcare, leveraging Taiwan's unique tech ecosystem to turn hospitals into smart organisms.

A new partnership for Procare Ambulance isn't just about expansion. It’s a multi-million dollar bet on a model that brings the hospital to the home.

Charles Anderson analyzes CorVel's CEO transition, examining how Sarah Scott's deep institutional knowledge, coupled with Michael G. Combs' ongoing strategic role, positions the company for sustained, tech-driven market leadership and operational excellence.

Washington state's innovative co-response teams are transforming crisis care, but a new campaign highlights a looming threat: federal Medicaid cuts.

A pioneer in professional chemical peels, PCA SKIN is strategically expanding its legacy into the booming at-home market. Their new Triple Exfoliation Peel Pads exemplify operational innovation, offering clinic-grade results and barrier support for the discerning consumer.

A new study on runners reveals how vagus nerve stimulation improves recovery and sleep, pioneering a 'Stress Fitness' approach for athletes.

With strong data for volixibat, brelovitug, and LIVMARLI, Mirum (MIRM) de-risks its pipeline and sets the stage for growth. Here's the analysis.

A new AI platform using smartwatches just got FDA's Breakthrough nod, promising to predict heart failure crises before they happen from home.

Harvard-trained surgeon Dr. Babajide Ogunseinde is launching a book trilogy and digital ecosystem to globalize his innovative spine surgery technique.

As employers face a 9% cost surge, Summus hires ex-Humana exec Mike Tilton to scale its physician-led platform for high-cost, complex medical cases.

With Ozempic at generic prices and a new free-to-start model, Felix Health is making high-demand weight-loss drugs more accessible than ever for Canadians.

A new telehealth platform offers popular weight loss drugs for $149/month, but there's a catch: they aren't FDA-approved. Here's what you need to know.

A renowned patient safety expert returns to helm Alberta's quality watchdog, bringing a 'Just Culture' philosophy to a health system in crisis and transition.